Potential of Marine Terpenoids against SARS-CoV-2: An <i>In Silico</i> Drug Development Approach
In an emergency, drug repurposing is the best alternative option against newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, several bioactive natural products have shown potential against SARS-CoV-2 in recent studies. The present study selected sixty-eight...
Enregistré dans:
Auteurs principaux: | Alaka Sahoo, Shivkanya Fuloria, Shasank S. Swain, Sujogya K. Panda, Mahendran Sekar, Vetriselvan Subramaniyan, Maitreyee Panda, Ajaya K. Jena, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/52bb711a0a8f4bfc80875f0718b2bf1e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An Update on the Function, Biosynthesis and Regulation of Floral Volatile Terpenoids
par: Zhenglin Qiao, et autres
Publié: (2021) -
Commercial utilities and future perspective of nanomedicines
par: Rishabha Malviya, et autres
Publié: (2021) -
Separation and purification of plant terpenoids from biotransformation
par: Linhao Chen, et autres
Publié: (2021) -
Biosynthesis and regulation of terpenoids from basidiomycetes: exploration of new research
par: Qi Wang, et autres
Publié: (2021) -
Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects
par: Kah Min Yap, et autres
Publié: (2021)